Bosentan 62.5mg tablets United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

bosentan 62.5mg tablets

dr reddy's laboratories (uk) ltd - bosentan monohydrate - oral tablet - 62.5mg

OPSUMIT Israel - English - Ministry of Health

opsumit

j-c health care ltd - macitentan - film coated tablets - macitentan 10 mg - macitentan - opsumit ® is an endothelin receptor antagonist (era) indicated for the treatment of pulmonary arterial hypertension (pah, who group i) to delay disease progression. disease progression included: death, initiation of intravenous (iv) or subcutaneous prostanoids or clinical worsening of pah (decreased 6-minute walk distance, worsened pah symptoms and need for additional pah treatment). opsumit also reduced hospitalization for pah.